GREEN FRESH BIO issued a profit warning, expecting a net loss attributable to shareholders of approximately 11 million to 13.5 million yuan in the first half of the year, a year-on-year turnaround from profit to loss
GREEN FRESH BIO expects to incur a net loss attributable to shareholders of approximately RMB 11 million to 13.5 million in the first half of 2025, a significant turnaround from a net profit of RMB 23.08 million in the same period of 2024. The main reasons include a decline in the selling price and sales volume of hydrophilic colloid products, leading to a decrease in revenue and gross profit, as well as an increase in research and development expenses
According to the Zhitong Finance APP, GREEN FRESH BIO (01084) announced that the group expects to incur a net loss attributable to the owners of the company of approximately RMB 11 million to 13.5 million in the first half of 2025, while the net profit attributable to the owners of the company for the same period in 2024 was RMB 23.08 million.
The announcement stated that the group's performance deteriorated mainly due to the following factors: a decline in the selling price and sales volume of the group's main hydrophilic colloid products, leading to a decrease in revenue and gross profit during the reporting period; and an increase in research and development expenses related to technology and knowledge for producing current mainstream products and new products during the reporting period
